Camp4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	109.52	64.04	38.38	83.19
Cash & Short-Term Investments	109.52	64.04	38.38	83.19
Cash Growth	71.02%	66.86%	-53.86%	-
Other Current Assets	4.58	2.34	1.63	1.22
Total Current Assets	114.1	66.38	40.01	84.41
Net Property, Plant & Equipment	2.82	10.3	13.31	16.79
Other Long-Term Assets	0.89	1.62	1.62	1.35
Total Assets	117.81	78.31	54.95	102.55
Accounts Payable	0.18	1.21	1.04	2.15
Accrued Expenses	5.63	4.83	3.3	3.43
Short-Term Debt	-	-	0.41	-
Current Portion of Leases	0.29	2.99	3.06	2.37
Unearned Revenue	9.39	0.39	-	-
Other Current Liabilities	0.03	0.18	-	-
Total Current Liabilities	15.51	9.6	7.81	7.95
Long-Term Debt	-	-	0.09	-
Long-Term Leases	1.69	5.49	8.64	10.03
Other Long-Term Liabilities	52.9	0.07	0	0
Total Long-Term Liabilities	54.59	5.57	8.72	10.03
Total Liabilities	70.1	15.16	16.53	17.93
Common Stock	0.01	0	0	0
Additional Paid-in Capital	339.85	274.9	36.23	33.14
Retained Earnings	-292.16	-211.75	-159.96	-110.67
Minority Interest	-	-	162.15	162.15
Shareholders' Equity	47.7	63.14	-123.73	-77.53
Total Liabilities & Equity	117.81	78.31	54.95	102.55
Total Debt	1.97	8.49	12.18	12.4
Net Cash (Debt)	107.54	55.55	26.2	70.8
Net Cash Growth	93.59%	112.05%	-63.00%	-
Net Cash Per Share	3.54	11.85	66.33	-
Book Value	47.7	63.14	-123.73	-77.53
Book Value Per Share	1.57	13.46	-313.26	-
Tangible Book Value	47.7	63.14	-123.73	-77.53
Tangible Book Value Per Share	1.57	13.46	-313.26	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q